Stephanie Slevin
John Radcliffe Hospital(GB)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Immune cells in cancer, Microscopic Colitis
Most-Cited Works
- → Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis(2021)190 cited
- → New Insights into the Mechanisms of Action of Anti–Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease(2015)54 cited
- → Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis(2020)53 cited
- → Phenotypic and functional heterogeneity of human intermediate monocytes based on HLA‐DR expression(2018)24 cited
- → Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis(2024)21 cited
- → Infliximab Selectively Modulates the Circulating Blood Monocyte Repertoire in Crohnʼs Disease(2016)10 cited
- → Clinical and Translational Outcomes in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease Receiving Vedolizumab(2017)3 cited
- → P93 Faecal microbiota transplant for refractory checkpoint inhibitor immunotherapy-related colitis(2021)2 cited
- → P064 Intestinal expression of LAG-3 correlates with inflammatory activity and response to biological therapy in ulcerative colitis(2018)2 cited